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Abstract 
 
Epizootic shell disease (ESD) in the American lobster, Homarus americanus, 
has a major impact on the southern New England lobster industry, yet there are no 
practical tools for managing the disease. The goal of this study was to identify bacterial 
probiotics that could be used to manage ESD in wild lobster populations. Candidate 
bacterial isolates (n = 24) were previously isolated from lobsters in Narragansett Bay 
and identified as having probiotic characteristics against ESD-associated bacteria 
Thalassobius sp. and Aquimarina macrocephali, or the fish pathogen Vibrio 
anguillarum. Healthy lobster post-larvae were exposed to five of the candidate strains 
isolated from lobsters and a probiotic bacterial strain isolated from the Eastern oyster, 
Crassostrea virginica (Phaeobacter inhibens S4). After several weeks of treatment, 
there were no significant differences in molting frequency, mortality, or growth of 
treated lobsters when compared with the control, indicating the candidate probiotics do 
not adversely affect lobster post-larvae. The effect of selected candidate probiotics (n = 
3) on progression of ESD in adult lobsters was tested for three months. Frequent molting 
due to high disease severity confounded long-term effects of the treatments, and no 
significant differences were seen in mortality, molting, growth, or disease progression. 
These results highlight the challenges involved in the development of tools for the 
management of a chronic disease with a poorly understood etiology. Future research 
should focus on a better understanding of microbe-microbe-host interactions in ESD, 
and the effect of environmental conditions on these interactions.
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Abstract                
 
Epizootic shell disease (ESD) in the American lobster, Homarus americanus, 
has a major impact on the southern New England lobster industry, yet there are no 
practical tools for managing the disease. The goal of this study was to identify bacterial 
probiotics that could be used to manage ESD in wild lobster populations. Candidate 
bacterial isolates (n = 24) were previously isolated from lobsters in Narragansett Bay 
and identified as having probiotic characteristics against ESD-associated bacteria 
Thalassobius sp. and Aquimarina macrocephali, or the fish pathogen Vibrio 
anguillarum. Healthy lobster post-larvae were exposed to five of the candidate strains 
isolated from lobsters and a probiotic bacterial strain isolated from the Eastern oyster, 
Crassostrea virginica (Phaeobacter inhibens S4). After several weeks of treatment, 
there were no significant differences in molting frequency, mortality, or growth of 
treated lobsters when compared with the control, indicating the candidate probiotics do 
not adversely affect lobster post-larvae. The effect of selected candidate probiotics (n = 
3) on progression of ESD in adult lobsters was tested for three months. Frequent molting 
due to high disease severity confounded long-term effects of the treatments, and no 
significant differences were seen in mortality, molting, growth, or disease progression. 
These results highlight the challenges involved in the development of tools for the 
management of a chronic disease with a poorly understood etiology. Future research 
should focus on a better understanding of microbe-microbe-host interactions in ESD, 
and the effect of environmental conditions on these interactions. 
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Introduction             
Heavy economic and cultural dependence on American lobsters (Homarus 
americanus) make coastal communities and stakeholders vulnerable in the face of 
disease outbreak. In 2016, roughly 159 million pounds of lobster were harvested in the 
U.S., worth nearly $670 million (NMFS 2018). Strong cultural ties with lobsters 
encourage tourism, further increasing their economic importance (Steneck et al. 2011). 
While southern New England makes up a small portion of this industry, this stock has 
been the most susceptible to an emergent disease in lobsters, known as epizootic shell 
disease (ESD).  
In 1996, ESD was reported in lobsters in Rhode Island (Castro and Angell 2000). 
Since this onset, annual lobster catches in Rhode Island have reduced significantly, with 
annual landings falling in value from $19 million in the 1990’s to around $12 million in 
2015 (NMFS 2016). It was estimated in 2012 that 10-30% of lobsters in Rhode Island 
had ESD (Castro and Somers 2012). This proportion of disease prevalence was even 
higher in egg-bearing female lobsters, where prevalence was reported at 60-80% (Castro 
and Somers 2012). While ESD prevalence remains low in the Gulf of Maine, the mean 
prevalence has more than doubled in the past 8 years from 0.5% to 1.2% (Reardon et al. 
in press). 
ESD is characterized by unsightly, melanized lesions that degrade the lobster’s 
carapace. These lesions significantly decrease the lobster’s market value, and can lead 
to negative impacts on lobster health, sometimes resulting in death (Smolowitz et al. 
2005; Hoenig et al. 2017). Although the etiology of ESD is not well understood, 
outbreaks are likely influenced by a number of factors including compromised condition 
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of the host, presence of putative pathogens in the ecosystem, and environmental stress 
(Tlusty et al. 2007; Gomez-Chiarri and Cobb 2012; Shields 2013, Barris et al. in press). 
Comparative analysis of microbial communities between ESD-infected and healthy 
lobsters suggest the disease is polymicrobial, and two species of bacteria, Thalassobius 
sp. and Aquimarina macrocephali (formerly designated Aquimarina ‘homari’), may be 
involved in the progression of ESD lesions (Chistoserdov et al. 2005; Quinn et al. 2012). 
Additionally, there is evidence of a transition to lower bacterial diversity in and around 
the lesions of laboratory-reared lobsters with shell disease, potentially initiated by 
dysbiosis in the microbial community on the shell (Feinman et al. 2017).  
While the decrease in lobster populations in southern New England is not solely 
due to ESD, high rates of ESD have been linked to a decrease in overall larval supply 
and subsequent population declines in Rhode Island (Wahle et al. 2009). It is 
hypothesized that ESD triggers molting in lobsters as a defense mechanism, so lobsters 
can get rid of the diseased shell before the disease negatively impacts the lobster (Laufer 
et al. 2005).  Consistent with this hypothesis, significantly high levels of the ecdysteroid 
receptor (a gene associated with molting) have been reported in lobsters with ESD, 
which may be triggering them to molt more frequently (Smolowitz et al. 2005; Castro 
and Somers 2012; Tarrant et al. 2012). If ovigerous females molt too early in an effort 
to rid themselves of the disease, this would result in the loss of their entire clutch of 
eggs.  Alternatively, lobsters can die from ESD if the lesions are so severe that ulceration 
of the epidermis occurs and prevent the lobster from molting successfully (Smolowitz 
et al. 2005). Mark-recapture studies on lobsters in the southern New England stock 
estimate that lobsters with moderate to severe ESD have a survival rate of only 30% 
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when compared to healthy lobsters (Hoenig et al. 2017). High mortality in diseased 
lobsters, and especially in ovigerous females, could explain population declines and the 
poor larval recruitment observed in southern New England (Hoenig et al. 2017). 
Despite characterization of the bacterial community on ESD-associated lesions 
(Meres et al. 2012; Feinman et al. 2017), Koch’s Postulates have not been fulfilled for 
ESD (Gomez-Chiarri and Cobb 2012). Koch’s Postulates specify that in order to 
identify the causative agent of an infectious disease, four criteria must be met: the 
pathogen must be present in all cases of disease; the pathogen can be isolated from the 
diseased host and grown in pure culture; the pure culture must cause disease when 
inoculated into a new healthy host; and finally, the pathogen must be reisolated from 
the new host and shown to be the same pathogen (Fredricks and Relman 1996). The 
absence of a laboratory model that fulfills Koch’s Postulates makes ESD a particularly 
difficult disease to study, and leaves those who rely on lobsters for their livelihood with 
more questions than answers. Quinn and colleagues (2012) discovered that abrading the 
epicuticle of lobsters and then exposing them to A. macrocephali alone, or a suite of A. 
macrocephali, Thalassobius sp., and Pseudoalteromonas gracilis resulted in lesion 
formation. However, non-abraded lobsters with the same treatments did not form 
lesions, indicating that these bacteria may be opportunistically colonizing lesions and 
furthering their development rather than initiating disease (Quinn et al. 2012). 
Currently, there are no applied management tools for controlling or mitigating 
ESD in wild lobster populations. Since transmission and onset of the disease is not 
understood, typical disease mitigation strategies cannot be proven effective in the 
southern New England system.  When fishermen encounter a diseased lobster, they only 
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have a few options: remove the lobster from the population; throw the lobster back in 
the water after catching; or sell the lobster for processed meat at a significantly reduced 
price. Additionally, lobsters lack an adaptive immune system that is characteristic of 
vertebrates, rendering traditional vaccines aiding in disease prevention an unviable 
option (Vazquez et al., 2009). We propose that probiotics could offer an alternative, 
novel tool for disease management. Probiotics are naturally occurring microorganisms 
that can provide health benefits to the host. While often thought of as food supplements, 
probiotics can also be added to water for aquatic organisms. These microorganisms have 
already shown disease protection in many other invertebrates and fish in aquaculture 
farm settings (Verschuere et al. 2000; Karim et al., 2013; Wu et al., 2014; Zhao et al., 
2016; Safari and Paolucci, 2017).  
Probiotic bacteria may confer benefits to the host in a number of ways, including 
competition with pathogenic bacteria, or modulating the immune system of the host 
(Perez-Sanchez et al. 2014; Zhao et al. 2016). These mechanisms of action can give 
organisms an advantage when fighting disease (Newaj-Fyzul et al. 2014). Probiotics are 
a favorable alternative to other treatments, like antibiotics, because probiotics do not 
select for antibiotic-resistant bacteria. While the application of probiotics in a wild 
fishery is more challenging than administration in an aquaculture farm, probiotics could 
offer a promising approach for ESD treatment if they can be incorporated in currently 
used lobster fishing practices.   
Due to the high prevalence of ESD in southern New England and expansion 
within the Maine lobster fishery, fishermen need tools to sustain the fishery long-term 
and avoid economic consequences. Previous work in our collaborative, interdisciplinary 
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probiotic group at the University of Rhode Island (URI) has identified 24 bacterial 
strains from the shells of healthy-appearing lobsters in Narragansett Bay in 2016 that 
exhibit probiotic characteristics (Underwood 2018). These strains were tested against 
putative ESD pathogens, Thalassobius sp. and Aquimarina macrocephali, to identify 
features characteristic of probiotic bacteria, including the ability to: 1) inhibit the growth 
of putative ESD pathogens; 2) form strong biofilms; and 3) compete with putative 
pathogens in co-incubation experiments (Zhao et al. 2016). Other criteria considered 
when selecting probiotics included: 4) the ease in which the bacterial strains can be 
cultured; 5) if the strain is safe to use on the host; 6) ability of the strain to enhance 
physiological processes such as growth; or 7) ability of the strain to slow the progression 
of disease (Perez-Sanchez et al. 2014).  
Based on our understanding of how candidate probiotics isolated from lobsters 
interacted with putative ESD pathogens in vitro (Underwood 2018), we tested the effect 
of treatment with candidate bacterial strains on lobsters in vivo. This involved 
examining the safety of candidate probiotic strains on post-larval lobsters and testing 
the effect of selected candidate probiotics on the progression of ESD lesions in adult 
lobsters. Determining the efficacy of probiotics in slowing or stopping the progression 
of ESD can help establish probiotics as a potential disease mitigation tool for ESD, or 
diseases similar to ESD.   
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Methods           
1) Bacterial Strains 
 Isolation, growth, and characterization of potential probiotics was conducted by 
Grace Underwood and Hilary Ranson at the University of Rhode Island (Underwood 
2018). These strains (Table 1) were cryogenically preserved for further characterization 
and testing for in vivo trials.   A probiotic isolate known to protect larval oysters against 
challenge with bacterial pathogens, Phaeobacter inhibens S4 (Karim et al. 2013) was 
included as control. 
 
Table 1. Candidate probiotics used in this research. 
* Spontaneous streptomycin-resistant (Smr) strains were developed in previous research 
and were used in PL Experiment 3 (Underwood 2018).  
 
 
 
 
Isolate 
ID 
16s Sequencing 
Identification 
ZOI (mm) 
against 
Thalassobius sp. 
ZOI (mm) against 
Aquimarina 
macrocephali 
Biofilm 
(OD 580) 
B* Bacillus sp. 2 4.33 2.88 
L210* Loktanella maritima 2 0 3.71 
L211 Loktanella maritima 1.7 0 3.71 
P01 Pseudoalteromonas sp. 4.3 0 3.17 
P11 Pseudoalteromonas sp. 0 2.2 3.32 
P14* Pseudoalteromonas sp. 2.5 0 3.24 
P18 Pseudoalteromonas sp. 0 1.6 2.89 
P21 Pseudoalteromonas sp. 1.17 0 2.18 
P22 Pseudoalteromonas sp. 1.83 0 3.71 
S4* Phaeobacter inhibens 1 1.4 3.89 
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Bacterial Growth Conditions 
Bacterial species routinely grown included A. macrocephali I32.4, Thalassobius 
sp. I31.1 (Chistoserdov et al. 2005), and the selected potential probiotic isolates (Table 
1; Underwood 2018).  If available, spontaneous streptomycin-resistant (Smr) strains 
developed in previous research were used in PL experiment 3.  This included: L. 
maritima 06-YPC210 Smr, Pseudoalteromonas sp. 03-YP014 Smr, and Bacillus sp. 06-
YP001 Smr (Underwood 2018), and P. inhibens S4Smr (Zhao et al. 2016). Bacterial 
isolates were grown at room temperature (23°C) on YP30IOS (10 g peptone, 2 g yeast, 
60 g of Instant Ocean Salt™ and 30 g agar, dissolved in 1 L deionized water, pH 7.0; 
with or without 100 µg/mL Sm depending on the isolate) agar plates or in YP30IOS 
liquid media in 50 mL polypropylene culture tubes with shaking (150 rpm).  
 
2) Post-larval (PL) lobster probiotics screening 
In order to detect any adverse effects of the candidate probiotic bacterial strains 
on survival and health, lobsters at the post-larval stage, a more vulnerable and easier to 
handle life stage than adults, were exposed to candidate probiotics (Table 1). Three 
experiments were performed, in which conditions to test the candidates were 
progressively optimized.  
 
PL Experiment 1 
Developmental stage three and four lobster post-larvae (PL) were obtained from 
the Mount Desert Oceanarium & Lobster Hatchery in Bar Harbor, Maine and brought 
to the East Farm Fisheries Center at URI on September 14, 2016. Plastic 750 mL 
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containers were filled with artificial seawater (ASW; 35 psu, 16°C) and 3 x 30 mL 
medicine cups were secured in each of the 750 mL containers. Small holes had been 
punched into the medicine cups using a syringe needle (25G) to ensure water flow and 
one PL was placed in each medicine cup. PLs were left to acclimate for two days.  
Four randomly assigned 750 mL containers were used for each treatment, for a 
total of 12 PLs per treatment, 3 lobsters per container. There was one control group and 
seven experimental treatment groups (B, L210, L211, P14, P21, P22, and S4; Table 1). 
Experimental treatments were administered at a concentration of 104 colony forming 
units (CFU) per mL of seawater via addition to their container by pipette (85-125 µL 
per well, dependent on bacterial stock concentration), two days after acclimation began. 
Five days later, any PLs that died were replaced with extra PLs and a second treatment 
was administered. Twenty-four hours after the second probiotic treatment, all PLs were 
exposed to putative pathogen, Thalassobius sp., at a concentration of 104 CFU/mL. PLs 
were then left in their containers for another 15 days, for a total of 20 experimental days. 
Each day, mortality (number of PLs dead), molting (number of PLs that molted), salinity 
(psu), and temperature (°C) were monitored. PLs were fed frozen Artemia sp. (Sally's 
Frozen Brine Shrimp™, San Francisco Bay Brand, Newark, CA) daily and debris was 
removed from containers 1-2 hours after feeding. Water changes occurred every four 
days, with half of the total volume in the 750 mL holding container being exchanged. 
Temperature during this experiment was maintained at 16°C. At the end of the 
experiment, photographs were taken of PLs.  
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PL Experiment 2 
Stage four and five PLs were obtained on March 30th, 2017 from the Sound 
School, a vocational aquaculture high school in New Haven, Connecticut, and brought 
to the Center for Marine Life Sciences at URI (Narragansett, RI). PLs were acclimated 
in a fifteen-gallon aquarium tank with ASW (30 psu, 18°C) for 24 h, and were then 
placed in six-well plates. Six-well plates were used instead of a shared container, like in 
PL experiment 1, to limit effects PLs would have on each other and to increase statistical 
power. Each well contained one PL and 10 mL of artificial seawater. PLs were left to 
acclimate for three days. There were two 6-well plates per treatment, for a total of 12 
PLs per treatment. There was one control group, which received no treatment, and 12 
experimental treatment groups (Table 1). Full water changes were administered daily 
using a serological pipette roughly 1 h after PLs were fed frozen Artemia sp. Lids were 
removed from the 6-well plates to better promote oxygen transfer into the water and the 
plates were held at room temperature (18-20°C).  
Experimental treatments were administered at a concentration of 104 CFU/mL 
via addition to their container by pipette (12-20 µL per container, dependent on bacterial 
stock concentration) once a week for two weeks, with treatments starting on April 3, 
2017. Each day, mortality (number of PLs dead), molting (number of PLs that molted), 
salinity (psu), and temperature (°C) was monitored. The experiment was halted after 
two weeks when cumulative mortality reached almost 70%. PLs were photographed at 
the beginning and end of the experiment under a dissecting microscope to look for 
lesion-like marking or spots using Lumenera Infinity-1 microscope camera and Infinity 
Capture software (Lumenera Corporation, Ottowa, ON). 
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PL Experiment 3 
Experimental Design and husbandry 
Stage seven and eight lobster post-larvae were obtained from the Sound School 
(New Haven, CT), and transported to the Center for Marine Life Sciences at URI on 
September 13, 2017. During transportation, PLs were held in ambient seawater from the 
Sound School and an ice pack. Upon arrival, PLs were transferred into individual 250 
mL glass culture dishes (Carolina Biological Supply Co., Burlington, NC) with seawater 
(29-31 psu salinity) from Narragansett Bay filtered through 2µm pore-size filter and 
kept between 14-18°C. The containers were kept in a water bath at (target temperature 
of 16°C) to maintain temperature stability. All containers were wrapped in black 
electrical tape so that PLs would not be able to see each other in order to reduce potential 
stress due to their aggressive behavior. Containers were randomly assigned a candidate 
probiotic and a unique identifier, with ten PLs per treatment. There were six different 
experimental treatments treatment (BSmr, L210Smr, L211, P14Smr, and S4Smr, and 
AT, a mix of A. macrocephali, or Thalassobius sp.; Table 1) and one control group 
which received no treatment. PLs acclimatized in the lab for seven days were 
photographed under a dissecting microscope (15x magnification) using a Lumenera 
Infinity-1 microscope camera. Images were used to measure PL size using Infinity 
Capture imaging software and count lesion-like markings or spots on their shell. 
Additional pictures were taken of all PLs (including dead) on days 25 and 40 of the 
experiment.  
On day 1, PLs were exposed to their designated probiotic treatment at a 
concentration of 104 CFU/mL of seawater via addition to their container by pipette (150-
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250 µL per container, dependent on bacterial stock concentration). PLs were exposed 
to their treatment for 24 h, at which point water was partially changed (150 out of 250 
mL of seawater). PLs were treated once a week for 25 days and then twice a week for 
an additional 15 days. One day before treatments were administered, PLs were given a 
full (250 mL) water change. Mortality and molting occurrence were recorded daily. PLs 
were fed daily with frozen Artemia sp. Water in the holding containers was partially 
changed each day about 1 h after feeding, with 150 of 250 mL (16°C, 29-31 psu salinity) 
seawater being exchanged, so that excess food was removed. Before water changes, 
three randomly selected PL containers were chosen each day for testing of the following 
water quality parameters: ammonia (ppm), nitrate (ppm), and pH using the API 
Saltwater Master Test Kit (Mars Fishcare North America, Inc.), dissolved oxygen (DO, 
mg/L) using a Milwaukee MW600 portable DO meter (Milwaukee Instruments, Rocky 
Mount, NC), and salinity (psu) using a refractometer. Temperature loggers (HOBO, 
Water Temp Pro v2, Onset Computer Corporation, Bourne, MA) were deployed in the 
water baths to record ambient water temperature every 10 min. Additionally, dissolved 
ammonium levels (µmol) were measured in all experimental containers on day 35 after 
the start of treatments (two days after a probiotic treatment) and on day 40 (4 days after 
a probiotic treatment). Dissolved ammonium concentration was measured using 
standard colorimetric techniques (Solorzano 1969) in an Orion Aquamate 7000 VIS 
Spectrophotometer©. Dissolved oxygen was also measured at the end of the experiment 
(day 40). Surviving PLs were photographed and stored in 30 mL 95% ethanol.  
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Bacterial Sampling and Evaluation of Colony Forming Units (CFU): 
Samples of water and biofilm on the surfaces of the incubation containers from 
Experiment 3 were collected from the PL containers to: 1) determine the ability of 
probiotics to persist after treatment; and 2) investigate effect of probiotic treatment on 
bacterial load. This sampling was performed only for streptomycin-resistant isolates 
(Table 1), to allow us to differentiate between probiotic counts (determined on Sm 
media) versus total bacterial counts in the containers (determined on media without Sm).  
Water and biofilm samples were taken immediately after probiotics were administered 
(day 0) and on days 1, 3, and 6 after probiotics treatment during the first week of the 
experiment, from 3 randomly selected containers. Biofilm samples from all containers 
were also taken on the last day of the experiment (day 40, Table 2). For water samples, 
approximately 1.5 mL of water was removed from PL holding containers and placed in 
a micro centrifuge tube. For the first four collection time points, three samples were 
taken from each treatment. For biofilm samples, a sterile polyester-tipped applicator 
was used to swab the entire circumference of PL containers. The applicator was then 
vigorously stirred in 1 mL of ASW for 20 seconds. Serial 1:10 dilutions up to 10-6 were 
performed for each sample, and all dilutions were spot plated in triplicate (10 µL/spot) 
on to YP30 agar plates (to measure total bacterial load) and onto YP30Sm agar with 
antibiotic (streptomycin, 200µg/mL). The plates were incubated at room temperature 
(18-20°C) for at least 2 days or until colonies formed. After incubation, all colonies 
were counted, counts for each dilution were averaged, and the average CFU/mL was 
calculated for each treatment. The morphology of colonies on YP30Sm plates was 
evaluated to confirm it corresponded to the candidate probiotic.  
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Table 2. Sampling timeline for water and swab samples for determination of bacterial 
concentrations (CFU/mL). Sampling started before probiotic treatments started (day 0), 
and ended after 40 days when the experiment was terminated. All water and swab 
samples were collected as described in the methods for every time point. 
 
CFU Sampling Timeline 
Date, Time 
9/21/17, 
7:00am 
9/21/17, 
5:00pm 
9/22/17, 
4:00pm 
9/24/17, 
4:00pm 
9/27/17, 
4:30pm 11/1/17, 9:00am 
# Day - 0 1 3 6 40 
Number of 
containers 
sampled for SmR 
bacterial 
concentrations in 
water 3 3 3 3 3 0 
Number of 
containers 
sampled for total 
bacterial 
concentrations in 
water 3 0 1 3 1 0 
Number of 
containers 
sampled for SmR 
bacterial 
concentrations in 
surfaces 0 0 3 0 3 [Control, BSmR, 
S4SmR, L211, AT] = 7 
  
P14SmR = 6 
 
 L210SmR = 5 
 
Number of 
containers 
sampled for total 
bacterial 
concentrations in 
surfaces 0 0 1 0 1 
Treatments 
Sampled 
Control, BSmR, S4SmR, P14SmR, L210SmR 
 
Control, BSmR, S4SmR, 
P14SmR, L210SmR 
 
 
 
3) Diseased Adult Lobster Probiotic Testing 
In order to test the ability of the candidate probiotics to slow ESD progression, 
one laboratory trial was run with sublegal-sized lobsters from Narragansett Bay, RI with 
ESD. Lobsters averaged 82.5 mm (± 2.1 mm SD) carapace length and included 34 males 
and 6 females. Lobstermen from the RI Lobstermen’s Association collected the adult 
lobsters for this trial from outside of Fort Wetherill in Narragansett Bay. Lobsters were 
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transported to the Graduate School of Oceanography at URI in the Center for Marine 
Life Sciences, where each was placed in an individual 57 L tank with flowing seawater 
(roughly 300-500 mL/min) from Narragansett Bay, RI and maintained at a temperature 
of 16°C and 29-31 psu salinity. The trial took place starting in October of 2016 and 
ending in January of 2017, since this is typically after lobsters have molted and ESD 
condition was expected to be less severe (Castro and Somers 2012).  
Candidate probiotics for treatments were selected based on a combination of the 
in vitro data (Underwood 2018) and performance in PL screening experiments as 
determined.  The following criteria were used in the selection process: ease in which the 
candidate probiotic isolate can be cultured in the lab; ability to inhibit the growth of 
pathogens (ZOI) and form biofilms; and lack of toxicity or potential decrease in 
mortality of PLs during exposure experiments as compared to non-treated PLs. 
Experimental treatments included one control group which received no treatment (n = 
10 lobsters) and three experimental groups each tested with either B, P14, or S4 (Table 
1, n = 10 lobsters per treatment). Tanks were assigned to treatments randomly. Prior to 
treatment, water flow to the tanks was halted (15 min) to ensure adequate residence time 
for the probiotic treatments. Probiotics were added to lobster tanks twice a week at a 
concentration of 104 CFU/mL, and left to incubate in their tanks for 15 minutes, at which 
point water flow was resumed. 
Mortality (number of dead individuals), molting (number of individuals that 
molted), and tank water salinity (psu) and temperature (°C) were measured at least 3 
times a week. Lobsters were photographed (using Olympus Stylus TG-4 camera) and 
measured at the beginning and end of the trial to document and analyze changes in 
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percent cover of lesions on the lobsters over time. The camera was placed at a fixed 
distance for photographs and 7 pictures were taken for each lobster at the beginning and 
end (dorsal carapace, right lateral carapace, left lateral carapace, dorsal abdomen, right 
lateral abdomen, left lateral abdomen, dorsal claws).   
 
Data Analysis 
Survival and molting occurrence curves were analyzed using Prism 6.0 
(GraphPad Software, La Jolla, CA) to determine differences in mortality across 
treatments over time using a Log-rank Mantel-Cox statistical test.  For molting 
occurrence curves, PLs that died during the experiment were censored. Growth (change 
in carapace length from start to end of experiment) was analyzed using a one-way 
ANOVA in R Studio. The proportion of PLs with lesions in each treatment was 
determined and analyzed using a chi-square test in R Studio. The effect of treatment on 
changes in the amount of bacteria (CFU/mL) in water and biofilm samples over time 
was analyzed using a two-way ANOVA with pairwise multiple comparison post-hoc 
test (Tukey) in Prism 6. 
For the adult lobster trial, the percent change in lesion cover was measured for 
each lobster and placed in a binary category of ESD condition being “severe” or “not 
severe.” When an individual had more than 50% of their body covered in lesions, they 
were characterized as having severe ESD (Tarrant et al. 2012). A series of chi-square 
tests were run in R Studio to investigate if mortality, molting, or disease severity differ 
significantly based on treatment. 
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Results           
PL Experiment 1 
Over the course of the 20-day experiment, there were no significant differences 
in survival or molting occurrence between treatments (Fig. 1). At the end of the 
experiment, pinpoint, circular melanized lesion-like markings on the lobster’s shells 
were observed (Figs. 2, 3). While there were no significant differences between 
treatments, the proportion of PLs with lesions was higher in the L210 treatment (Fig. 
2). Since lobster appearance was not documented at the beginning of the experiment, it 
is uncertain whether these lesions developed during the experiment as an effect of 
treatment. The addition of Thalassobius sp. on day 6 of the experiment did not have an 
effect on PLs survival, molting or presence of lesions.  
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Figure 1. Effect of candidate probiotic treatment on percent survival and percent 
molting occurrence of lobster post-larvae (PL) over 20 days during Experiment 1. At 
time 0, probiotics were administered to PLs and one day later they were challenged with 
Thalassobius sp. No significant differences in survival or molting between treatments 
were observed (survival Log-rank test p=0.42, molting Log-rank test p=0.74).  
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Figure 2. Effect of candidate probiotic treatment on mean proportion of lobster post-
larvae with lesions after 15 days during PL Experiment 1. Averages were taken from 
the proportion of lobsters in each treatment (3 per beaker, 4 replicates) with lesions. No 
statistical differences were observed between groups (chi-square p=0.43). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Photograph of a representative lobster post-larvae with potential shell 
disease lesions. This PL was treated with probiotic candidate Bacillus sp. for 20 days 
in PL Experiment 1.  
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PL Experiment 2 
This experiment was terminated 15 days after start of treatment due to heavy 
mortality (69% of all PLs died). Significant differences in survival were observed 
between control and L210 treatments, which showed the highest mortality (Log-rank 
test p=<0.0001, Fig. 4). Water temperature during this experiment ranged from 19-
20°C. At this time point, percent survival was lowest in the control and L210 (0 and 
8.3% survival, respectively) treatments when compared with the rest of the treatments 
(ranging from 25-75% survival). There were no significant differences in molting 
between treatments (Fig. 4), and lesions were not observed on PLs at either the start or 
end of the experiment.  
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Figure 4. Effect of candidate probiotic treatment on percent survival (top) and percent 
molting occurrence (bottom) of lobster post-larvae over 14 days during PL Experiment 
2. At time 0, probiotics were administered to PLs. Significantly higher mortality was 
observed in the L210 and control treatments (Survival Log-rank test p=<0.0001, 
Molting Log-rank test p=0.10) than in other treatments.  Asterisks denote the level of 
significance (p-value) when compared to the control.  
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PL Experiment 3 
Survival, Molting, Growth, and Lesions: 
Throughout the 40-day experiment there were no significant differences in 
survival between treatments (Fig. 5). Cumulative mortality levels remained below 50% 
in all of the treatments. Treatment with a mix of A. macrocephali and Thalassobius sp., 
(AT) did not have a significant effect on PLs compared to other treatments, including 
the control. On day 34 of the experiment there was a mortality event where 12 PLs died 
(0-30% mortality in each treatment) (Fig. 5). There was no significant difference in 
molting occurrence between treatments (Fig. 5). There were also no significant 
differences in growth of the lobsters that molted and survived the entire experiment (Fig. 
6). Two individuals from different treatments (L211 and P14Smr) developed lesions 
during the experiment (Fig. 7), and both died (on days 26 and 33, respectively).  
 
Water Quality Parameters: 
 Average temperature ranged from 14-18°C and salinity ranged from 30-33 psu 
during the 40-day experiment (Fig. 8). Temperature fluctuations were a result of the 
water cooling system at the Center for Marine Life Science and changes in temperature 
in the source water from Narragansett Bay. Fluctuations were also observed in dissolved 
oxygen, nitrate, and pH, with ideal water quality parameters being observed after full 
water changes. Nitrate concentrations remained low until day 31, after which nitrate 
concentrations periodically spiked until the end of the experiment (Fig. 18).  There were 
no significant differences between treatments in ammonium or dissolved oxygen 
measurements taken at the end of the experiment (Figs. 9, 10). 
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Effect of probiotic on bacterial levels: 
Significantly higher levels of some of the candidate probiotics could be detected 
in samples of water (as determined by counts of streptomycin resistant bacteria) from 
the PL containers on day 0 (right after the probiotic treatment was administered; S4Smr 
and BSmr was significantly higher than P14Smr) and day 1 (24 hours after treatment; 
S4 was significantly higher than all treatments) (Two-way ANOVA, p=<0.05; Fig. 11 
and Table 4). Significant differences in probiotic concentration between treatments on 
day 0, right after addition of candidate probiotics to the containers, were probably due 
to differences in the relationship between CFU and OD580 (the parameter used to 
estimate bacterial concentration in the stocks) between candidate probiotic isolates. 
There was a significant interaction between time and probiotic concentration (Two-way 
ANOVA, p=<0.05; Table 4). By day 3 and 6 (after full water changes in PL containers 
occurred) there was no statistical difference between treatments, but Smr bacteria could 
be detected at low levels in water samples from all treatments, including the control, on 
day 6 (Fig. 11).   
Neither treatment nor time had a significant effect on probiotic bacterial 
concentration on the water-immersed surfaces of PL containers (Two-way ANOVA 
effect of treatment p=0.07, time p=0.09, time x treatment interaction p=0.12; Fig. 12 
and Table 6). Post-hoc pair-wise comparisons of treatments within day 1 (24 hours after 
treatments were administered), however, showed that S4Smr had a significantly higher 
biofilm concentration (1.64x105 CFU/ml) when compared with BSmr (2.67x104 
CFU/ml) (Two-way ANOVA, p=<0.05, Tables 5 and 6). By days 6 and 40, there was 
no statistical difference between treatments, but Smr bacteria could still be detected at 
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low levels in water samples from all treatments, including the control (Fig. 12, Tables 
5 and 6). Colony morphologies of the control samples were variable between different 
PL containers and the day they were sampled.  
Treatment did not have a significant effect on total bacterial load (as measured 
on YP30 agar plates) in water samples 3 days after probiotics were administered (One-
way ANOVA p=0.34; Fig. 13) or in biofilm samples taken from PL container surfaces 
on day 40 (One-way ANOVA p=0.10; Fig. 14). 
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Figure 5. Effect of candidate probiotic treatment on percent survival and percent 
molting occurrence of lobster post-larvae over the course of the 40-day experiment 
during PL Experiment 3 (Log-rank Mantel-Cox test for survival p=0.98, and for molting 
p=0.42).  
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Figure 6. Effect of candidate probiotic treatment on average growth (mm) of lobster 
post-larvae that both molted and survived throughout PL Experiment 3. (One-way 
ANOVA p=0.17). Large black dots represent the mean, boxes represent upper and lower 
quartile, black line within the box represents the median, and whiskers indicate 
minimum and maximum values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Photographs of lobster post-larvae that developed lesions in PL Experiment 
3. These individuals were from the L211 (left) and P14 treatment (right). Both 
individuals died before the end of the experiment on days 26 and 33, respectively.  
 
n = 4 n = 4 n = 4 n = 4 n = 3 n = 3 n = 2 
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Figure 8. Representative water quality conditions in lobster post-larvae dishes during 
PL Experiment 3. Each day, three PL dishes were chosen at random to test water quality 
parameters.  
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Figure 9. Effect of candidate probiotic treatment on ammonium levels (µM) at two time 
points at the end of experiment during PL Experiment 3. The top figure is from samples 
taken on day 35 of the experiment, 2 days after probiotic treatment. The bottom figure 
is from samples on day 40 of the experiment, 4 days after probiotic treatment (One-way 
ANOVA for day 35, p=0.60; One-way ANOVA for day 40, p=0.19). Large black dots 
represent the mean, boxes represent upper and lower quartile, black line within the box 
represents the median, and whiskers indicate minimum and maximum values. 
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Figure 10. Effect of candidate probiotic treatment on dissolved oxygen (mg/L) in 
lobster post-larvae dishes on the last day of the experiment during PL Experiment 3. 
DO was recorded on day 40 of the experiment, 4 days after a probiotic treatment. 
Sample sizes ranged from 5-7 containers (One-way ANOVA p=0.10). Large black dots 
represent the mean, boxes represent upper and lower quartile, black line within the box 
represents the median, and whiskers indicate minimum and maximum values. 
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Figure 11. Effect of candidate probiotic treatment on average SmR bacterial 
concentration (CFU/mL, as determined on YP30Sm plates) from the water in lobster 
post-larvae dishes during the first week of PL Experiment 3. Error bars represent 
standard error. There were significant differences between treatments on day 0 and 1 
(Two-way ANOVA p=<0.0001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Effect of candidate probiotic treatment on average SmR concentration 
(CFU/mL, as determined on YP30Sm plates) on the surface of containers for PL 
Experiment 3. Error bars represent standard error. There were no significant differences 
between treatments over time (Two-way ANOVA p=<0.09), except on day 1, B was 
significantly lower than S4. 
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Figure 13. Effect of candidate probiotic treatment on average total bacterial 
concentration (in CFU/mL, YP30 media) from water samples collected from lobster 
post-larvae containers 3 days after probiotics were added for PL Experiment 3. Levels 
of SmR bacteria, as detected on YP30Sm agar plates, were subtracted from each of the 
treatments. Error bars show standard error and there were no significant differences 
between treatments (One-way ANOVA p=0.40). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Effect of candidate probiotic treatment on average total bacterial 
concentration (in CFU/mL, YP30 media) from biofilm samples collected from the 
surfaces of lobster post-larvae containers on day 40 of PL Experiment 3. Levels of SmR 
bacteria, as detected on YP30Sm agar plates, were subtracted from treatments. Error 
bars show standard error (One-way ANOVA p=0.55). 
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Adult Lobster Experiment 
Due to the high prevalence of ESD in RI (Castro and Somers, 2012) most (about 
50%) of the lobsters collected had moderate ESD at the start of the experiment, with 
lesions affecting roughly 20-60% of the carapace surface. Mortality throughout the 
experiment was very low, with only 2 individuals dying in total, one of which died on 
the last day of the experiment. In both cases, mortality resulted from an unsuccessful 
molt most likely induced due to the severity of ESD lesions. Throughout the experiment, 
27 of the 40 lobsters molted, and no statistically significant differences between 
treatments were detected (Log-rank test p=0.69; Fig. 15). Molting showed a significant 
interaction with disease severity (Chi-square p= 0.00059), indicating this was the main 
factor associated with molting, rather than treatment (Fig. 16). The number of lobsters 
characterized as having severe ESD at the beginning of the experiment was 5-6 
individuals per treatment (out of a total of 10). At the end of the experiment or time of 
molt (whichever came first), the severity of ESD either stayed the same or worsened for 
all individuals (Fig. 17). For lobsters that did molt, there was no significant difference 
in growth between treatments (One-way ANOVA p=0.82; Fig. 18). None of the 
treatments had a visible impact on lesion severity; however, no individuals displayed 
signs of ESD again after molting. 
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Figure 15. Effect of candidate probiotic treatment on percent molting occurrence of 
adult lobsters over 16 weeks. No statistical differences in molting were observed 
between treatments (Log-rank test p=0.69, Prism 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Relationship between molting occurrence and ESD severity for adult 
lobsters over 16 weeks. “High Severity” indicates lesions covered >50% of carapace. 
There was a significant relationship between severity of ESD and molting occurrence 
(Chi-square p= 0.00059, R Studio). 
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Beginning of Experiment End of Experiment   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Effect of candidate probiotic treatment on progression of ESD from 
beginning to end of the adult lobster experiment. Individuals in each treatment were 
characterized as “high” or “low” severity at the beginning and end of the experiment (or 
at the time the lobster molted). “High Severity” indicates lesions covered >50% of 
carapace. There were no significant differences between treatments and ESD worsened 
for all treatments (Beginning of experiment Chi square p=0.93, End of experiment Chi 
square p=0.81). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Effect of probiotic treatment on growth (mm) of lobsters that molted during 
the adult lobster experiment. There were no statistical differences in growth between 
treatments (One-way ANOVA p=0.82). Boxes represent upper and lower quartile, black 
line within the box represents the median, and whiskers indicate minimum and 
maximum values. 
n = 5 n = 8 n = 7 n = 7 
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Discussion           
 The aim of this research was to 1) develop methods for in vivo screening of 
candidate probiotics against ESD in American lobsters; and 2) test the effect of these 
candidate probiotics on the progression of ESD in adult lobsters. Three different PL 
screening assays were performed to determine the best method for rapid screening of 
several candidate probiotics on live lobsters. While probiotic screenings have been 
conducted in other juvenile crustacean species for disease control applications, such as 
the spiny lobster, Panulirus ornatus, (Nguyen et al. 2014), crayfish (Safari and Paolucci 
2017), and various shrimp species (Hai and Fotedar 2010; Kumar et al. 2016), these 
experiments have never been conducted for Homarus americanus in the context of ESD. 
Based on these screening experiments, several potential probiotics were selected for 
testing on adult lobsters with ESD. We found that: 1) potential probiotic isolates did not 
have adverse effects on lobsters at the post-larval (PL) stage; 2) several of the probiotic 
candidates may protect lobster PL from environmental stress; 3) there were no visual 
improvements to ESD lesions in an experiment performed with adult lobsters that had 
moderate to severe ESD before treatment. 
Our collaborative probiotic group at URI was able to select, identify, and test 
seven different candidate probiotic strains that were isolated from lobsters. One of these 
strains, P. inhibens S4, was isolated from the eastern oyster, Crassostrea virginica, and 
has proven disease protection in the larvae of hatchery-reared oysters (Karim et al. 
2013).  Each of the candidate probiotics displayed growth inhibition against A. 
macrocephali and/or Thalassobius sp., two putative ESD pathogens isolated from 
lobsters with lesions (Chistoserdov et al. 2005). The role of these putative pathogens in 
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ESD progression, however, is not clear (Meres et al. 2012; Quinn et al. 2012; Feinman 
et al. 2017), and this is a limitation for the selection of possible probionts. Our 
assumption was that the antibiotic activity against these ESD-associated bacteria, 
combined with the ability to form strong biofilms on lobster shells, would indicate the 
likelihood of being protective against ESD. 
Screening probiotic isolates on PLs allowed for pre-selection of the candidate 
probiotics with the highest potential for probiotic activity to be tested in labor-intensive 
adult lobster trials, and could be used as a model for future probiotic discovery strategy. 
We encountered several challenges in the development of screening protocols using 
lobster PLs, based on the need to keep PLs in individual containers due to their 
cannibalistic nature. In PL experiment 1, the design allowed for maintenance of water 
quality, but did not allow for high statistical power since three PLs were in each 
container. This concern was addressed in PL experiment 2 where PLs were kept in 
separate wells of 6-well plates, but the water temperatures that reached 20°C, which is 
known to be stressful to juvenile and larval lobsters (Waller et al. 2016), was likely 
detrimental to PL survival. The small volume of seawater in 6-well plates also could 
have led to poor water quality conditions such as low dissolved oxygen and high 
ammonia. In PL experiment 3, PLs were kept in larger glass bowls with frequent water 
changes and kept at a relatively constant temperature. This method was the most 
successful in providing a static system yet keeping physiological stress low as measured 
by mortality.  
Despite differences in experimental design, we can use consistent findings from 
all three PL screening experiments to infer the effect of treatment of potential probiotics 
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on lobsters at a vulnerable, early life stage. The PL screening assays indicated that most 
of the candidate probiotic treatments did not have statistically significant toxic effects 
on individuals. Survival was low in PL experiment 2, likely due to adverse 
environmental conditions, most probably temperature stress. Interestingly, several of 
the probiotic isolates significantly enhanced PL survival as compared to the control 
group in these conditions. In larviculture of the blue swimming crab, Portunus 
pelagicus, a probiotic water additive was shown to be effective at improving water 
quality and enhancing survival when challenged with a pathogen (Dad Talpur et al. 
2013).  An effect of treatment on water quality parameters (dissolved oxygen, 
ammonium), however, was not seen in PL experiment 3. Further research is needed to 
confirm the ability of candidate probiotic treatment to increase PL survival under 
conditions of environmental stress, as well as determine the mechanisms involved in 
this protection. These could include, for example, the potential of probiotics to influence 
water quality parameters such as nitrate, ammonia, and pH or to protect PLs against 
opportunistic infections triggered by stressful conditions (Verschuere et al. 2000; Hai 
and Fotedar 2010; Dad Talpur et al. 2013).  
Molting occurrence was not influenced by treatment in any of the experiments 
conducted in this study. Subsequently, probiotic treatments did not have significant 
effects on growth of lobsters that did molt during the experiments. This finding is 
inconsistent with evidence of enhanced growth from certain probiotic dietary 
application in Homarus gammarus larvae (Daniels et al. 2010) and Panaeus monodon 
(Boonthai et al. 2011), and with probiotic water additive application in freshwater 
crayfish  (Dash et al. 2016). However, Middlemiss and colleagues (2015) found that 
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adding Bacillus sp. to the water of larval and post-larval H. gammarus had no significant 
impacts on growth or weight (Middlemiss et al. 2015). In the future, larger sample sizes 
and longer trials could help more rigorously determine treatment impacts of probiotics 
on growth. 
Combined evidence from these experiments indicated that Loktanella maritima 
L210 should not be further considered as a probiotic candidate.  This evidence included   
the higher (although not significant) incidence of lesions on PLs in experiment 1 and 
the fact that L210 was the only strain that did not show protective effects on survival 
under severe environmental stress in experiment 2.  Additionally, bacteria from the 
genus Loktanella have been observed in cultures from ESD lesions and have been 
observed around lesions of laboratory-reared lobsters (Feinman et al. 2017) 
The goal of measuring bacterial concentrations in water and biofilm samples 
from PL containers in experiment 3 was to determine if the candidate probiotics persist 
in the water, form biofilms on the PLs’ containers, and/or impact overall bacterial load. 
Of the six bacterial treatments tested in this trial, four of them were streptomycin-
resistant strains, which allowed measurement of their concentration by plating onto Sm-
inoculated YP30 media. This experiment had several limitations that should be 
considered when interpreting the data.  Contrary to expectations, colonies were present 
on YP30Sm plates from water samples collected from control (no probiotic treatment) 
containers on day 6 and biofilm samples collected on all days. There are some potential 
explanations for this observation: a) the presence of streptomycin resistant 
bacteria naturally occurring in the experimental system; b) contamination of some 
control containers with probiotic treatments due to spray or experimental errors on 
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delivering treatments; and/or c) contamination of the media used in sample 
dilution prior to spot plating.  In order to distinguish between these potential 
explanations, colony appearance was also considered when counting colonies.  Colony 
morphology of the biofilm control samples were variable between days and containers, 
indicating that it is unlikely that the media used for serial dilutions was contaminated, 
since the same media was used for water samples, which showed no streptomycin 
resistant bacterial growth from most control samples. Based on the data available, it is 
not possible to distinguish between the other two alternatives, but further work would 
be required to identify the colonies present on the plates. Another caveat of the 
experiment was variation in probiotic concentrations between treatments when added to 
PL containers, likely due to the inaccuracy of optical density measurements for 
determining of bacterial concentrations, which prevented accurate estimation of 
differences in bacterial loads between treatments. This variability could also be due to 
artifacts in the sampling (e.g. probiotic isolates were not homogenously distributed in 
the containers before bacterial sampling). 
Despite these caveats, significantly higher levels of S4 and B were observed in 
water from the containers one day after treatment as compared to control treatments, 
suggesting that these strains can persist in the system for at least one day after treatment.  
Interestingly, although B showed comparable levels to S4 in water on day 1 after initial 
treatment, the containers treated with S4 showed significantly higher levels of bacteria 
in the glass surfaces than B. This is consistent with in vitro data showing that S4 is a 
stronger biofilm former than B (Underwood 2018) and previous research showing that 
biofilm formation contributes to the probiotic ability of S4 in larval oysters (Zhao et al. 
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2016).  P. inhibens S4 and other isolates from the Roseobacter clade, have been shown 
to protect various aquatic animals from disease (D ’alvise et al. 2012; Karim et al. 2013; 
Prol García et al. 2014).  Despite being an oyster bacterial isolate, S4 was one of the 
only strains that showed a zone of inhibition against both lobster putative pathogens, A. 
macrocephali and Thalassobius sp.  These results, in conjunction with existing evidence 
of S4 protection against disease in oysters (Karim et al. 2013; Zhao et al. 2016) warrant 
further study of this particular isolate.  
Probiotics had no measurable effect on overall bacterial load in the PL 
containers, as measured by CFU/mL. Conserved 16S ribosomal RNA sequencing, an 
approach commonly used to characterize microbiomes (Quinn et al. 2012; Closek et al. 
2014; Arfken et al. 2017), of water and biofilm samples during PL assays could better 
elucidate how the microbial communities change over time and between treatments. 
Sequencing and quantification of bacteria through qPCR would also give a more 
accurate representation of how the candidate probiotics persist in the water. Further 
experiments looking at biofilm formation of candidate probiotics on lobster shells 
should be performed. Examining the success of probiotic colonization on shells could 
help us understand how successful probiotics could be competing with putative 
pathogens in ESD lesions (Verschuere et al. 2000; Zhao et al. 2016).  
Based on the results from the PL screening assays and the results from the in 
vitro testing of antimicrobial activity and the ability of form biofilms, we decided to test 
S4, B, and P14 on adult lobsters that had ESD.  After 3 months of treatments performed 
twice a week, the probiotics did not have a measureable effect on halting ESD 
progression.  Our results were confounded by the fact that most lobsters molted at 
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different points throughout the experiment, making long-term tracking of ESD 
progression challenging. It was surprising that so many lobsters molted, considering the 
time of year (October-January) is not during the normal molting period for Rhode Island 
lobsters (Castro and Angell 2000; Castro and Somers 2012). Our experiments show that 
molting was related to the severity of ESD lesions, a result consistent with previous 
observations that molting behavior is altered in ESD lobsters, and may be a strategy 
used by lobsters to prevent the development of systemic infections (Smolowitz et al. 
2005; Castro et al. 2006). It is also possible that the disease was too severe for the 
candidate probiotics to have any sort of therapeutic effect, or for us to detect an effect. 
Carapace erosions cannot be repaired, so if shell cuticles were already damaged, it 
would be difficult to measure improvements in progression of the disease.  Additionally, 
bacterial communities in the lesions may have been too established and persistent for 
probiotics to be effective. Considering the lack of an experimental model of ESD in 
which the disease can be induced after treatment with candidate probiotics, lobsters with 
beginning stages of ESD should be used in the future to more effectively track disease 
progression. Different types of probiotic treatment delivery should also be considered, 
such as the filters saturated with candidate bacteria used in a study investigating the role 
of putative pathogens in lesion development (Quinn et al. 2012).   
It may also be important to consider the probiotic isolates in this study in the 
context of other H. americanus diseases, or other crustacean diseases in general – in 
both fishery and aquaculture settings. For example, probiotics could be tested against 
H. americanus diseases with a better laboratory model, such as the bacterial Vibrio 
fluvalis infection (Beale et al. 2008) or Gaffkemia (Clark et al. 2013). Given the 
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importance of crustacean fisheries and aquaculture for global protein sources (Bondad-
Reantaso et al. 2012), it is imperative to better understand their diseases and how to 
manage them.   
Investigating the use of probiotic treatments in a wild fishery has not yet been 
researched to our knowledge. Implementing such technology is challenging, 
considering the scope of the disease in southern New England lobster populations 
(Hoenig et al. 2017), and that the etiology of ESD is not well understood. The current 
body of literature for probiotic treatments in diseased marine organisms generally 
applies to hatchery-based aquaculture systems rather than wild marine populations. 
More research must be done in order to make recommendations about how to best apply 
probiotics to the lobster fishery, or if probiotics will even be a viable option. Our goal 
was to investigate the use of probiotic treatments by placing diseased lobsters in a 
“probiotic bath.” Lobstermen in RI expressed that they would be willing to keep a 
reasonably-sized probiotic bath on their fishing vessel, place diseased lobsters in this 
bath for a pre-determined amount of time, and then return lobsters back into the ocean. 
Our experiments were designed and conducted with this application model in mind, and 
we explored various probiotic screening methods to try and determine which candidate 
probiotic would be best-suited for application in the fishery.  
The current application of probiotics in this study did not prove to be effective 
in slowing or stopping the progression of ESD. However, we have developed a model 
for screening candidate probiotics on PLs.  An adult lobster experiment such as that 
described here can verify if candidates chosen from screening assays are effective. 
Further research determining the ability of probiotic isolates to form biofilms on lobster 
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carapaces may help inform application in this context. Experiments examining biofilm 
formation on sterile fragments of lobster shell (Underwood 2018) could also be used as 
an effective screening tool, and could potentially be used instead of using live PLs. 
Focusing on microbe-microbe interactions in future experiments will not only help us 
better understand the probiotics mechanism of action, but could also provide more 
information about how the bacteria from ESD lesions interact with potentially beneficial 
bacteria. 
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Additional Tables         
 
 
Table 3. Effect of candidate probiotic treatment on average SmR bacterial concentration 
(CFU/mL, as determined on YP30Sm plates) in water from lobster post-larvae dishes 
during the first week of PL Experiment 3. 
 
 
 
 
Table 4. Two-way ANOVA showing effect of probiotic treatment on average SmR 
bacterial concentration (CFU/mL, as determined on SmYP30 plates) in water from 
lobster post-larvae dishes during the first week of PL Experiment 3 (Prism 6). 
Probiotic Concentration in Water 
Two-way ANOVA P-value Significant? Summary 
Interaction 0.0008 Yes *** 
Time 0.0004 Yes *** 
Treatment < 0.0001 Yes **** 
Day 0 
Control vs. B <0.05 Yes * 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 <0.05 Yes **** 
B vs. L210 >0.05 No ns 
B vs. P14 <0.05 Yes * 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 <0.05 Yes ** 
P14 vs. S4 <0.05 Yes *** 
Day 1 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 <0.05 Yes **** 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
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B vs. S4 <0.05 Yes *** 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 <0.05 Yes ** 
P14 vs. S4 <0.05 Yes * 
Day 3 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
Day 6 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
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Table 5. Effect of candidate probiotic treatment on average SmR concentration 
(CFU/mL, as determined on YP30Sm plates) on the surface of containers for PL 
Experiment 3. 
 
 
 
 
 
 
 
Table 6. Two-way ANOVA showing effect of probiotic treatment on average SmR 
concentration (CFU/mL, as determined on YP30Sm plates) on the surface of 
containers for PL Experiment 3 (Prism 6). 
Probiotic Concentration in Water 
Two-way ANOVA P-value Significant? Summary 
Interaction 0.1236 No ns 
Time 0.0699 No ns 
Treatment 0.0864 No ns 
Day 0 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 <0.05 Yes * 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
Day 1 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
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Day 3 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
Day 6 
Control vs. B >0.05 No ns 
Control vs. L210 >0.05 No ns 
Control vs. P14 >0.05 No ns 
Control vs. S4 >0.05 No ns 
B vs. L210 >0.05 No ns 
B vs. P14 >0.05 No ns 
B vs. S4 >0.05 No ns 
L210 vs. P14 >0.05 No ns 
L210 vs. S4 >0.05 No ns 
P14 vs. S4 >0.05 No ns 
